14 results
PRE 14A
TYRA
Tyra Biosciences Inc
5 Apr 24
Preliminary proxy
4:20pm
Innovation Organization, the Foundation for the National Institutes of Health, Girl Effect and Life Science Cares. She has co-developed an immersive
DEF 14A
TYRA
Tyra Biosciences Inc
28 Apr 22
Definitive proxy
4:07pm
New Diagnostics (FIND). Mr. More currently serves on one of the governing boards of the Biotechnology Innovation Organization (BIO). He received his
10-K
2021 FY
TYRA
Tyra Biosciences Inc
3 Mar 22
Annual report
4:31pm
to become resistant to previous generations of kinase inhibitors poses a challenge to drug developers, one that we believe will demand innovation for a long … and continuing technological innovation to develop and maintain our proprietary position. We also rely on trade secrets and know-how that may
10-Q
w7wkyqrj6sz8vu6v
3 Nov 21
Quarterly report
4:31pm
424B4
9ob414ub1n1g
15 Sep 21
Prospectus supplement with pricing info
4:10pm
S-1/A
EX-4.2
1znv4 9g71vls
9 Sep 21
IPO registration (amended)
6:08am
S-1/A
24ory1
9 Sep 21
IPO registration (amended)
6:08am
S-1
EX-4.2
nb65aii iyzwof7twu
20 Aug 21
IPO registration
4:07pm
S-1
miiu n0kgtj
20 Aug 21
IPO registration
4:07pm
DRS/A
dm9rsbc2ziqrl yrc
2 Jul 21
Draft registration statement (amended)
12:00am
DRS
i66fni ksr5
28 May 21
Draft registration statement
12:00am
- Prev
- 1
- Next